| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.027 | 0.6 |